3月3日A股投資避雷針︱永安行:終止重大資產重組事項
路維光電股東興森科技及其一致行動人擬合計減持不超2.00%股份;三美股份董事、常務副總經理佔林喜擬減持不超0.7887%股份;北陸藥業股東三峽油漆擬減持不超過0.61%股份;上海洗霸表示固態電池相關業務暫未形成長期穩定收入;天正電氣產品應用於機器人行業的營業收入不到200萬元,佔比極小;華豐股份發電機組並非數據中心與算力直接相關的核心設備;永安行終止重大資產重組事項;華依科技終止2024年度向特定對象發行A股股票

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.